Molecules,2015年
Natarajan Arumugam, Abdulrahman I. Almansour, Raju Suresh Kumar, J. Carlos Menéndez, Mujeeb A. Sultan, Usama Karama, Hazem A. Ghabbour, Hoong-Kun Fun
LicenseType:CC BY |
2 Synthesis and Crystal Structures of Benzimidazole-2-thione Derivatives by Alkylation Reactions [期刊论文]
Molecules,2015年
El Sayed H. El Ashry, Yeldez El Kilany, Nariman M. Nahas, Assem Barakat, Nadia Al-Qurashi, Hazem A. Ghabbour, Hoong-Kun Fun
LicenseType:CC BY |
Molecules,2015年
Abdulrahman I. Almansour, Natarajan Arumugam, Raju Suresh Kumar, Govindasami Periyasami, Hazem A. Ghabbour, Hoong-Kun Fun
LicenseType:CC BY |
Molecules,2015年
Mohammad Shahidul Islam, Abdullah Mohammed Al-Majid, Assem Barakat, Saied M. Soliman, Hazem A. Ghabbour, Ching Kheng Quah, Hoong-Kun Fun, Richard A. Bunce, Philippe Belmont, Wim Dehaen
LicenseType:CC BY |
Molecules,,202015年
Ayman El-Faham, Sherine N. Khattab, Hazem A. Ghabbour, Hoong-Kun Fun, Muhammad Farooq, Mohammad A. Wadaan, Nael Abutaha
LicenseType:Unknown |
Eight novel N′-(2-oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazone derivatives 4a–h were synthesized and fully characterized by IR, NMR (1H-NMR and13C-NMR), elemental analysis, and X-ray crystallography. The cyto-toxicity and in vitro anti-cancer evaluation of the prepared compounds have been assessed against two different human tumour cell lines including human liver (HepG2) and leukaemia (Jurkat), as well as in normal cell lines derived from human embryonic kidney (HEK293) using MTT assay. The compounds 3e, 3f, 4a, 4c, and 4e revealed promising anti-cancer activities in tested human tumour cells lines (IC50 values between 3 and 7 μM) as compared to the known anti-cancer drug 5-Fluorouracil (IC50 32–50 μM). Among the tested compounds, 4a showed specificity against leukaemia (Jurkat) cells, with an IC50 value of 3.14 μM, but this compound was inactive in liver cancer and normal cell lines.
Molecules,2015年
Rashad Al-Salahi, Ibrahim Alswaidan, Hazem A. Ghabbour, Essam Ezzeldin, Mahmoud Elaasser, Mohamed Marzouk
LicenseType:CC BY |